This inventor holds 24 USPTO granted patents and 5 EPO patents, primarily in Banknote Handling Technology. Top assignees: Glory Ltd., Daiichi Sankyo Company, Limited, Plexxikon Inc.. Active years: 2005-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Koto-Ku, JP (2011)
- Hyogo, JP (2012 - 2015)
- Himeji, JP (2005 - 2016)
- Tokyo-To, JP (2013 - 2016)
- Tokyo, JP (2015 - 2020)
Company Filing History:


Years Active: 2005-2020
Areas of Expertise:
Title: **Shinji Matsuura: Innovator in Kinase Modulation**
Introduction
Shinji Matsuura is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of medicinal chemistry. With an impressive portfolio of 24 patents, Matsuura's work focuses on the synthesis of compounds that modulate various kinases, crucial elements in cellular signaling pathways.
Latest Patents
Matsuura's latest patents delve into the synthesis of compounds that are designed to modulate receptor protein kinases, specifically targeting c-Kit, c-Fms, and Flt3. The compounds are articulated in a formula that offers considerable potential for therapeutic development. His innovative processes not only include the preparation of active compounds but also highlight synthetic intermediates that may serve as precursors for further research. This groundbreaking work plays a vital role in advancing treatments for conditions influenced by these kinases.
Career Highlights
Throughout his career, Shinji Matsuura has collaborated with notable companies in the pharmaceutical industry, including Glory Ltd. and Plexxikon Inc. His dedication to innovation and research in kinase modulation has established him as a valuable contributor to the scientific community. With a focus on synthesis and therapeutic applications, Matsuura has significantly impacted the pharmacological landscape.
Collaborations
Matsuura has worked alongside distinguished professionals such as Hajime Morino and Toshio Numata. Their collaborations have led to advancements in drug development and a deeper understanding of kinase mechanisms. The synergy between these inventors showcases the importance of teamwork in fostering innovation in the realm of biochemical research.
Conclusion
Shinji Matsuura's inventiveness and commitment to advancing science are reflected in his numerous patents and collaborative efforts. His work in the synthesis of kinase-modulating compounds continues to pave the way for innovative treatments, making a valuable contribution to the field of medicinal chemistry. As a leading figure in this domain, Matsuura exemplifies the spirit of innovation and dedication to improving health outcomes through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile